Detalhe da pesquisa
1.
How I treat sickle cell disease with hematopoietic cell transplantation.
Blood
; 134(25): 2249-2260, 2019 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31697818
2.
Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies.
Blood
; 132(13): 1438-1451, 2018 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29997222
3.
Hematopoietic Stem Cell Transplantation to Treat Leukodystrophies: Clinical Practice Guidelines from the Hunter's Hope Leukodystrophy Care Network.
Biol Blood Marrow Transplant
; 25(12): e363-e374, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31499213
4.
Sirolimus-associated pericardial effusion with cardiac tamponade and interstitial pneumonitis in a hematopoietic stem cell transplant recipient.
Pediatr Transplant
; 23(4): e13425, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31012209
5.
Bone Marrow-Derived Mesenchymal Stromal Cells from Patients with Sickle Cell Disease Display Intact Functionality.
Biol Blood Marrow Transplant
; 23(5): 736-745, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28132869
6.
Use of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases.
Biol Blood Marrow Transplant
; 21(10): 1845-52, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26095669
7.
Mesenchymal stromal cells to modulate immune reconstitution early post-hematopoietic cell transplantation.
BMC Immunol
; 16: 74, 2015 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26674007
8.
IL-12hi rapamycin-conditioned dendritic cells mediate IFN-γ-dependent apoptosis of alloreactive CD4+ T cells in vitro and reduce lethal graft-versus-host disease.
Biol Blood Marrow Transplant
; 20(2): 192-201, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24239650
9.
Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity.
Blood
; 119(22): 5088-103, 2012 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-22403259
10.
Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure.
Blood Adv
; 7(10): 2196-2205, 2023 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36724508
11.
Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCT.
Blood Adv
; 7(14): 3725-3734, 2023 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37042921
12.
Reduced-intensity single-unit unrelated cord blood transplant with optional immune boost for nonmalignant disorders.
Blood Adv
; 4(13): 3041-3052, 2020 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32634238
13.
Immune Tolerance Strategies in Siblings with Infantile Pompe Disease-Advantages for a Preemptive Approach to High-Sustained Antibody Titers.
Mol Genet Metab Rep
; 4: 30-34, 2015 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26167453